Valuation Metrics Reflect Elevated Price Levels
Grauer & Weil’s current P/E ratio stands at 22.66, a level that places it firmly in the very expensive category relative to its own historical range and the broader commodity chemicals sector. This is a significant increase compared to prior valuations when the stock was rated merely expensive. The price-to-book value ratio has also climbed to 3.19, underscoring the premium investors are paying for the company’s net assets.
Other valuation multiples reinforce this elevated pricing stance. The enterprise value to EBIT ratio is 19.43, while the EV to EBITDA ratio is 16.55, both indicating stretched valuations compared to typical sector benchmarks. These multiples suggest that the market is pricing in robust earnings growth and operational efficiency, which may be optimistic given recent performance trends.
Peer Comparison Highlights Relative Overvaluation
When compared with peers in the commodity chemicals industry, Grauer & Weil’s valuation remains on the higher side, though not the most expensive. For instance, Navin Fluorine International trades at a P/E of 56.95 and an EV/EBITDA of 34.40, while Himadri Speciality Chemical’s P/E is 33.58 with an EV/EBITDA of 25.04. However, Grauer & Weil’s valuation is notably higher than Deepak Nitrite’s P/E of 40.64 and Atul’s 32.37, both considered expensive but not very expensive.
This relative positioning suggests that while Grauer & Weil is not the costliest stock in the sector, its valuation premium is significant enough to warrant caution, especially given its recent price performance and fundamental metrics.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Financial Performance and Returns Contextualise Valuation Concerns
Despite the lofty valuation, Grauer & Weil’s return on capital employed (ROCE) remains robust at 28.70%, and return on equity (ROE) is a respectable 15.14%. These figures indicate efficient capital utilisation and profitability, which partly justify the premium valuation. However, the company’s dividend yield is modest at 0.71%, which may not appeal to income-focused investors seeking yield in the commodity chemicals space.
Examining stock returns relative to the Sensex reveals a mixed picture. Over the past week and month, Grauer & Weil has underperformed the benchmark, with declines of 2.20% and 4.18% respectively, compared to Sensex’s 0.94% and 0.35% gains. Year-to-date, the stock is down 5.82%, while the Sensex has risen 2.28%. Over the one-year horizon, the stock’s return is deeply negative at -19.20%, contrasting sharply with the Sensex’s 9.66% gain.
Longer-term returns are more favourable, with three-year and five-year returns of 48.57% and 223.74% respectively, both outperforming the Sensex’s 35.81% and 59.83%. The ten-year return is particularly impressive at 510.81%, more than double the Sensex’s 259.08%. This historical outperformance highlights the company’s growth potential but also raises questions about the sustainability of current valuations given recent underperformance.
Mojo Score and Grade Downgrade Signal Elevated Risk
MarketsMOJO’s proprietary scoring system has downgraded Grauer & Weil’s Mojo Grade from Sell to Strong Sell as of 13 Oct 2025, reflecting deteriorating valuation attractiveness and price risk. The Mojo Score currently stands at 23.0, a low figure signalling weak overall fundamentals and market sentiment. The market capitalisation grade remains low at 3, indicating limited scale relative to peers.
This downgrade aligns with the shift in valuation grading from expensive to very expensive, signalling that investors should exercise caution. The combination of stretched multiples, recent price weakness, and a negative short-term return profile suggests that the stock may be vulnerable to further downside if earnings growth fails to meet elevated expectations.
Is Grauer & Weil (India) Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Historical Valuation Trends and Market Price Action
Grauer & Weil’s current market price of ₹70.09 is near its 52-week low of ₹68.25, down from a high of ₹111.45 within the same period. This decline of approximately 37% from the peak price reflects market scepticism about the sustainability of the company’s earnings growth and valuation multiples. The stock’s day change of -3.28% further emphasises short-term selling pressure.
Given the elevated P/E and P/BV ratios, the stock’s price appears to be pricing in significant growth and margin expansion. However, the absence of a PEG ratio (0.00) suggests that earnings growth expectations may be uncertain or not clearly defined, adding to valuation risk. Investors should weigh these factors carefully against the company’s operational metrics and sector outlook.
Sector Outlook and Investment Implications
The commodity chemicals sector is subject to cyclical demand fluctuations, raw material price volatility, and regulatory pressures. While Grauer & Weil has demonstrated strong capital efficiency and long-term returns, the current valuation premium may limit upside potential in a sector facing macroeconomic headwinds.
Investors considering exposure to Grauer & Weil should be mindful of the stock’s stretched valuation relative to peers and historical norms. The recent downgrade to Strong Sell by MarketsMOJO underscores the elevated risk profile. A cautious approach is warranted, with close monitoring of earnings updates and sector developments.
Conclusion: Valuation Premium Demands Prudence
Grauer & Weil (India) Ltd’s transition from expensive to very expensive valuation status, combined with a downgrade in its Mojo Grade to Strong Sell, signals a clear warning for investors. Despite strong ROCE and ROE metrics and impressive long-term returns, the current price multiples suggest limited margin for error. The stock’s recent underperformance relative to the Sensex and peers further accentuates downside risks.
For investors seeking exposure to the commodity chemicals sector, it may be prudent to explore alternatives with more attractive valuations and comparable growth prospects. Grauer & Weil’s premium pricing demands a high degree of confidence in sustained earnings momentum, which remains uncertain in the current market environment.
Unlock special upgrade rates for a limited period. Start Saving Now →
